A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the western world with prevalence of 20–33%. NAFLD comprises a pathological spectrum. Nonalcoholic fatty liver (NAFL) is at one end and consists of simple hepatic steatosis. On the contrary, nonalcoholic steatohepatitis (NA...
Saved in:
Main Authors: | Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/7109270 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling the Effects of Nonpharmaceutical Interventions on COVID-19 Spread in Kenya
by: Duncan K. Gathungu, et al.
Published: (2020-01-01) -
An Update on African Trypanocide Pharmaceutics and Resistance.
by: Keneth Iceland, Kasozi, et al.
Published: (2023) -
Characteristics of NAFLD Based on Hypopituitarism
by: Kazuhisa Kodama, et al.
Published: (2020-01-01) -
Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities
by: Fan Sijia, et al.
Published: (2023-06-01) -
A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease
by: Qingdong Guan
Published: (2019-01-01)